Koçak, Mehmet ZahidAktaş, GülaliDuman, Tuba TaslamacıoğluAtak, Burçin MeryemKurtkulağı, ÖzgeTekçe, HikmetBilgin, Satılmış2021-06-232021-06-2320202251-6581https://doi.org/10.1007/s40200-020-00595-0https://hdl.handle.net/20.500.12491/10392Aims Inflammation is a cardinal pathogenetic mechanism in diabetic kidney injury (DKI). The detection of microalbuminuria (MA) is very important in preventing end-stage renal failure in diabetic subjects. A combination of high monocyte and low lymphocyte counts are used as a marker of inflammation. Monocyte to lymphocyte ratio (MLR) is considered as a marker in inflammatory diseases. We aimed to evaluate the MLR levels in diabetic subjects as a predictive marker in detecting MA. Methods A total of 212 patients with type 2 diabetes mellitus (T2DM) were included in the study. Patients with T2DM were divided into two groups as MA and normoalbuminuria (NA). MLR of the groups were compared. Results There were 72 patients in MA and 140 patients in NA group. MLR of the MA and NA groups were 0.247 (0.131-0.540) and 0.211 (0.052-0.390), respectively (p < 0.001). There was a statistically significant correlation between MLR and MA (r = 0.228, p = 0.001). In multivariate backward logistic regression analysis, MLR, fasting blood glucose, HbA1c and presence of comorbid clinical diseases were determined as independent predictors of DKI. Conclusions We suggest that MLR could serve as a predictive and effective marker for DKI in diabetic subjects due to its strong correlation with MA and inexpensive and readily available nature.eninfo:eu-repo/semantics/closedAccessMonocyte lymphocyte ratioMicroalbuminuriaDiabetic Kidney InjuryInflammationType 2 Diabetes MellitusHbA1cArticle10.1007/s40200-020-00595-01929971002335530192-s2.0-85088802518Q2WOS:000556945200002N/A